Annual Shareholders Equity
$196.41 M
-$219.75 M-52.80%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual stockholders equity is $196.41 million, with the most recent change of -$219.75 million (-52.80%) on December 31, 2021.
- During the last 3 years, GBT annual shareholders equity has fallen by -$376.39 million (-65.71%).
Performance
GBT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$118.36 M
-$15.64 M-11.67%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly stockholders equity is $118.36 million, with the most recent change of -$15.64 million (-11.67%) on June 30, 2022.
- Over the past year, GBT quarterly shareholders equity has dropped by -$197.41 million (-62.52%).
Performance
GBT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
GBT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.8% | -62.5% |
| 3 y3 years | -65.7% | -83.2% |
| 5 y5 years | -38.4% | -58.0% |
GBT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -39.7% | at low |
| 5 y | 5-year | -66.1% | at low | -79.5% | at low |
| alltime | all time | -66.1% | -125.1% | -83.2% | -157.2% |
Global Blood Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $118.36 M(-11.7%) |
| Mar 2022 | - | $134.00 M(-31.8%) |
| Dec 2021 | $196.41 M(-52.8%) | $196.41 M(-36.3%) |
| Sep 2021 | - | $308.30 M(-2.4%) |
| Jun 2021 | - | $315.77 M(-13.1%) |
| Mar 2021 | - | $363.19 M(-12.7%) |
| Dec 2020 | $416.16 M(-28.1%) | $416.16 M(-9.1%) |
| Sep 2020 | - | $457.65 M(-7.7%) |
| Jun 2020 | - | $495.82 M(-5.3%) |
| Mar 2020 | - | $523.57 M(-9.5%) |
| Dec 2019 | $578.69 M(+1.0%) | $578.69 M(-12.1%) |
| Sep 2019 | - | $658.10 M(-6.5%) |
| Jun 2019 | - | $704.19 M(+26.5%) |
| Mar 2019 | - | $556.54 M(-2.8%) |
| Dec 2018 | $572.80 M | $572.80 M(+21.3%) |
| Sep 2018 | - | $472.20 M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $506.55 M(-5.8%) |
| Mar 2018 | - | $537.76 M(+68.7%) |
| Dec 2017 | $318.80 M(+71.1%) | $318.80 M(+23.4%) |
| Sep 2017 | - | $258.27 M(-8.3%) |
| Jun 2017 | - | $281.71 M(-6.9%) |
| Mar 2017 | - | $302.49 M(+62.4%) |
| Dec 2016 | $186.31 M(+32.3%) | $186.31 M(-11.3%) |
| Sep 2016 | - | $210.10 M(-5.5%) |
| Jun 2016 | - | $222.41 M(+76.3%) |
| Mar 2016 | - | $126.12 M(-10.4%) |
| Dec 2015 | $140.79 M(-385.4%) | $140.79 M(-9.1%) |
| Sep 2015 | - | $154.82 M(-328.8%) |
| Jun 2015 | - | -$67.67 M(-247.9%) |
| Mar 2015 | - | $45.75 M(-192.7%) |
| Dec 2014 | -$49.33 M(+89.9%) | -$49.33 M |
| Dec 2013 | -$25.97 M | - |
FAQ
- What is Global Blood Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual shareholders equity year-on-year change?
- What is Global Blood Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly shareholders equity year-on-year change?
What is Global Blood Therapeutics annual stockholders equity?
The current annual shareholders equity of GBT is $196.41 M
What is the all time high annual shareholders equity for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual stockholders equity is $578.69 M
What is Global Blood Therapeutics annual shareholders equity year-on-year change?
Over the past year, GBT annual stockholders equity has changed by -$219.75 M (-52.80%)
What is Global Blood Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of GBT is $118.36 M
What is the all time high quarterly shareholders equity for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly stockholders equity is $704.19 M
What is Global Blood Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, GBT quarterly stockholders equity has changed by -$197.41 M (-62.52%)